Our Achivements

Since January 2022, we have been exporting infusion Normal saline and Paracetamol for IV use as our core experience. We have since expanded to include multiple generic medicines, partnering with multiple manufacturers with facilities registered in the Ministry of Health to serve our clients in Middle Eastern countries with different partnership models.

One of our major achievements has been our success in Iraq and Kurdistan. Through direct purchase orders and tenders from the Ministries of Health in Iraq, Iran, and Saudi Arabia, we have been able to provide essential drugs at competitive prices with faster service while maintaining the highest quality standards, which is in line with our vision and mission statement.

We have gained extensive knowledge about the product requirements, specific packaging requirements, and regulatory procedures of our buyers. As a result, we have identified major buyers with $40 million purchases and become their exclusive procurement partner, which has enabled our company to experience substantial growth.

Our initial goal was to supply essential drugs within a short period, which built immense trust with our buyers. As a result, 100% of our business is now repeat business, and we are working hard to maintain our reputation with our prestigious clients. Our focus for the next few years is to increase our sales exponentially, and we are committed to ensuring the quality of our products and providing our best services to ensure customer satisfaction.